MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-KR-03-0166538
Randox Laboratories (India) Private Limited - healthcare in Bangalore, Karnataka, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹100.02 Cr
▲ 10% YoY
Net loss · FY 2025
₹7.94 Cr
Net margin -7.9%
EBITDA · FY 2025
-₹3.37 Cr
EBITDA margin -3.4%
Authorised capital
₹10 Cr
Registered with MCA
Paid-up capital
₹9.87 Cr
Issued & subscribed
Open charges
₹80 Lakh
Secured borrowings
Company age
22 yrs
Est. 2004
Employees · EPFO
114
Provident fund records
About Randox Laboratories (India) Private Limited
Data last updated:
Randox Laboratories (India) Private Limited is a private limited company based in Bangalore, Karnataka, India, a subsidiary of Randox Laboratories Limited United Kingdom. It operates in the medical and laboratory equipment segment of the healthcare sector. It was incorporated on 28 December 2004 and has been in existence for over 22 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U24230KA2004PTC070372. Its GSTIN is 29AADCR0074K1Z7 (Karnataka). The company holds 5 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹10 Cr and a paid-up capital of ₹9.87 Cr. It is led by directors including Umesh and Stephen Peter Fitzgerald.
Its last annual general meeting (AGM) was held on 31 December 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Bangalore, Karnataka.
As per the financials filed for FY 2025, the company reported a revenue of ₹100.02 Cr, a growth of 10% compared to the previous year. For the same year it recorded a net loss of ₹7.94 Cr (net margin -7.9%) and EBITDA of -₹3.37 Cr (EBITDA margin -3.4%). Revenue has grown at a compounded annual rate (CAGR) of 15% over three years and 11% over five years.
The company has about 114 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹80 Lakh on record. Court records list 2 cases involving the company, including 2 filed by the company; 1 case is pending. The company has 1 deal on record (1 funding round), with disclosed funding of ₹8.87 Cr; the latest was in May 2009.
Randox Laboratories (India) Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-KR-03-0166538). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website randox.com.
Company details
CIN U24230KA2004PTC070372
Registration Number 070372
Incorporation Date 28 December 2004
ROC Bangalore
Listing Status Unlisted
Company Status Active
Date of Last AGM 31 December 2025
Date of Balance Sheet 31 March 2025
Parent Company Randox Laboratories Limited United Kingdom
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-KR-03-0166538
CIN history
Randox Laboratories (India) has one previous CIN (Corporate Identification Number): U24230MH2004PTC150251. The current CIN is U24230KA2004PTC070372, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24230KA2004PTC070372 | Current |
| U24230MH2004PTC150251 | Previous |
Recognitions & Rankings of Randox Laboratories (India)
Contact details
Randox Laboratories (India) Private Limited's registered office is in Bangalore, Karnataka. Its website is randox.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressPlot No. 191 – 195 & 246 – 250 KIADB Industrial Area Bommasandra Jigani Link Road Rajapura Ho, Bli Jigani, Bangalore, Karnataka, India – 562106
- IndustryHealthcare, Medical & Laboratory Equipment
To see the full contact details of Randox Laboratories (India) Private Limited, buy the company report.
Comprehensive company report
Randox Laboratories (India) Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Randox Laboratories (India) is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Randox Laboratories (India) Private Limited, buy the company report.
Financials of Randox Laboratories (India) Private Limited
FY 2025 filings availableRandox Laboratories (India) Private Limited reported revenue of ₹100.02 Cr (up 10% YoY) for FY 2025.
Revenue · FY 2025
₹100.02 Cr ▲ 10%
Net loss · FY 2025
₹7.94 Cr margin -7.9%
EBITDA · FY 2025
-₹3.37 Cr margin -3.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 10%
3 years · compounded
▲ 15%
5 years · compounded
▲ 11%
EBITDA CAGR growth
1 year
▲ 58%
3 years · compounded
▼ 28%
5 years · compounded
▼ 19%
Revenue has grown at a compounded annual rate (CAGR) of 11% over five years, including 10% growth in the latest year. EBITDA rose 58% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹3.37 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹7.94 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -3.4% | ||||
| Net Profit Margin | -7.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Randox Laboratories (India) Private Limited, buy the company report.
Board of directors of Randox Laboratories (India) Private Limited
Randox Laboratories (India) has 3 current directors and 10 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Umesh | Director | 08 Aug 2022 | 4 Years 2 Months | Current |
| Stephen Peter Fitzgerald | Director | 28 Dec 2004 | 21 Years 9 Months | Current |
| Linda Ann Magee | Director | 10 Apr 2025 | 1 Years 6 Months | Current |
Auditor
Randox Laboratories (India) Private Limited is audited by Walker Chandiok & Co LLP for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Walker Chandiok & Co LLP | FY 2022 | 00107N/N500013 |
Shareholding
The shareholding of Randox Laboratories (India) Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Randox Laboratories (India) Private Limited, buy the company report.
Charges & borrowings
Open charges
₹80 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 06 Jun 2014 | 10628463 | Citi Bank N.A. | ₹80 Lakh | Open |
Total charge records: 1 View all charges
Deals & funding
Randox Laboratories (India) Private Limited has 1 deal on record (1 funding round), with disclosed funding of ₹8.87 Cr; the latest was in May 2009.
Total deals
1
Funding round
1
Disclosed funding
₹8.87 Cr
Deals on record (1 of 1)
| When | Deal | Amount | Parties |
|---|---|---|---|
| May 2009 | Funding round | ₹8.87 Cr | Investors: Randox Laboratories Limited |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Randox Laboratories (India) Private Limited has 2 court cases on record: 2 filed by Randox Laboratories (India). 1 case is pending and 1 is disposed.
Total cases
2
Filed by the company
2
Pending
1
Disposed
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 2 | 0 | 1 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Karnataka | Court case (CRL.P) | Filed by the company against Truth Labs International LLP, and 1 other | Disposed |
| High Court of Karnataka | Writ petition | Filed by the company against The Joint Commissioner of Customs Post Assessment Group | Pending |
To see the full case history of Randox Laboratories (India) Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Randox Laboratories (India) Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Randox Laboratories (India) Private Limited has a workforce of 114 employees on its EPFO records as of Apr 04, 2024, across 2 active EPFO establishments.
Employee count
114
Active EPFO establishments
2
Employee growth
8.57%
GST
Randox Laboratories (India) has 5 GST registrations: 1 active and 4 cancelled or inactive.
Total GSTINs
5
Active
1
Cancelled / inactive
4
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AADCR0074K1Z7 | Karnataka | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Randox Laboratories (India) Private Limited, buy the company report.
Recent activity
Randox Laboratories (India) Private Limited has 13 board changes on record since 2004: 4 appointments and 9 cessations. The latest: Linda Ann Magee ceased to be Additional Director on 30 Dec 2025.
AGM
Randox Laboratories (India) Private Limited last Annual general meeting of members was held on 31 Dec 2025 as per latest MCA records.
Ceased
Linda Ann Magee ceased to be Additional Director.
Appointed
Linda Ann Magee was appointed as Director.
Filing
Randox Laboratories (India) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore.
Ceased
Umesh ceased to be Additional Director.
Ceased
Prashant Suresh Shanbhag ceased to be Director.
Appointed
Umesh was appointed as Director.
Ceased
Richard Kelly ceased to be Additional Director.
Ceased
Brian Walsh ceased to be Director.
Appointed
Richard Kelly was appointed as Director.
Ceased
Biswa Jyoti Sahoo ceased to be Alternate Director.
Ceased
Ashwin Dinakaran ceased to be Alternate Director.
5 earlier events are in the company report.
News
Frequently asked questions
Randox Laboratories (India) is an active private limited company based in Bangalore, Karnataka, India. The company works in medical and laboratory equipment, within the healthcare industry. It was incorporated on 28 December 2004 (22+ years old) and is registered under CIN U24230KA2004PTC070372.
Randox Laboratories (India) has 3 current directors:
- Umesh - Director
- Stephen Peter Fitzgerald - Director
- Linda Ann Magee - Director
The latest financial statements of Randox Laboratories (India) on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 31 December 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Randox Laboratories (India) is 29AADCR0074K1Z7, registered in Karnataka. The company has 5 GST registrations in all, of which 1 is active and 4 are cancelled or inactive.
The CIN (Corporate Identification Number) of Randox Laboratories (India) is U24230KA2004PTC070372. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Randox Laboratories (India) has 2 court cases on record: 2 filed by the company. 1 is pending.
Randox Laboratories (India) was incorporated on 28 December 2004, making it 22+ years old. It is registered with the Registrar of Companies, Bangalore.
Randox Laboratories (India) has 1 deal on record (1 funding round), with disclosed funding of ₹8.87 Cr; the latest was in May 2009.
Linda Ann Magee ceased to be Additional Director on 30 Dec 2025. Linda Ann Magee was appointed as Director on 10 Apr 2025. Umesh ceased to be Additional Director on 30 Nov 2022. Randox Laboratories (India) has 13 board changes on record in total.
Yes, Randox Laboratories (India) is registered as a medium enterprise under Udyam registration (number: UDYAM-KR-03-0166538).